XR8-69
XR8-69 is a SARS-CoV-2 PLpro inhibitor that shows low micromolar antiviral potency in SARS-CoV-2-infected human cells.
Product Specifications
CAS Number
[2817811-10-0]
UNSPSC
12352005
Target
SARS-CoV
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/xr8-69.html
Solubility
10 mM in DMSO
Smiles
O=C(N[C@@H](C1=CC=CC(C2=CC=C(CNC(C)=O)S2)=C1)C)C3=CC(NC4CNC4)=CC=C3C
Molecular Formula
C26H30N4O2S
Molecular Weight
462.61
References & Citations
[1]Shen Z, et al. Design of SARS-CoV-2 PLpro Inhibitors for COVID-19 Antiviral Therapy Leveraging Binding Cooperativity. J Med Chem. 2021 Oct 19:acs.jmedchem.1c01307.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-139892/XR8-69-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-139892/
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
37443151 3x1.0μg DNA
PPP1R2P4 CRISPR All-in-one AAV vector set (with saCas9)(Human)
Ask
View Details ![Rabbit Polyclonal VPS4B Antibody [DyLight 755]](https://cdn.genprice.uk/genprice/genprice2.png)